Oregon Health and Science University

  • Image


    Our mission is to enhance the efficiency and quality of rigorously translating research ideas into impact.
  • In collaboration with the Technology Transfer and Collaborations & Entrepreneurship offices at Oregon Health & Science University (OHSU), the Oregon Clinical and Translational Research Institute (OCTRI) announced three new funded projects for the 2021 drug discovery track of the Biomedical Innovation Program. This program supports drug discovery platforms and early-stage therapeutic technology
  • Oregon Health and Science University
    Case report Forms (CRFs) are standardized documents in which the study team records data collected in a clinical trial. CRFs should support compliant collection and documentation of research data by following Good Clinical Practice and Good Documentation guidelines. This seminar will cover definitions, operational considerations, and data requirements, while focusing on data outputs (data analysis
  • Oregon Health and Science University
    This class will cover the most common questions regarding survey design and administration - and provide the answers! Topics we will cover include: Writing great survey questions Choosing previously validated questions Selecting survey software and administration methods Maximizing response rates Budgeting for your survey Designing your survey to facilitate data analysis Piloting your survey. We
  • Oregon Health and Science University
    Subject Injuries are adverse experiences that arise directly from or contributed to by the study drug(s), study device(s), or study procedures that would not have been expected from the standard treatment for the patient's condition, progression of condition, or other reasons. This training introduces the topics of subject injuries, ethical positions, informed consent language, and clinical
  • ABOUT THE POSITION As the co-Director of the Oregon Clinical Translational Research Institute (OCTRI) Informatics program, you will serve in a highly visible role, providing strategic direction and overseeing OCTRI informatics operations, as well as serving as the leader for the OHSU Research Data Warehouse. This position plays a key leadership role in all aspects of research informatics, data
  • Image of a machine head with DNA bases flowing out the back.
    Oregon Health and Science University
    This meeting is organized and hosted by the Genomic Data Science Working Group of the National Human Genome Research Institute (NHGRI). The primary purpose of the workshop is to stimulate discussion around the opportunities and obstacles underlying the application of machine learning (ML) methods to basic genome sciences and genomic medicine, to define the key scientific topic areas in genomics
  • OCTRI Scholar Dr. David Sheridan (left) and Dr. Matthew Hansen (right), both OHSU Emergency Medicine physicians, were awarded OCTRI Biomedical Innovation Program (BIP) funding and project support in 2018 to develop a new bedside technology for quickly detecting sepsis using an accurate and objective measure of capillary refill time (CRT). In the last 3 years, Drs. Sheridan and Hansen leveraged
  • A team of researchers led by Dr. Dora M. Raymaker, one of few openly autistic researchers, used a community-based participatory research (CBPR) approach to conduct an inaugural study on autistic burnout. Findings draw attention to the syndrome, long recognized by autistic people but not formally investigated, and will inform future research, prevention strategies, and interventions. Autistic
  • In collaboration with the Technology Transfer and Collaborations & Entrepreneurship offices at Oregon Health & Science University (OHSU), the Oregon Clinical and Translational Research Institute (OCTRI) announced four new funded projects for the 2021 device and diagnostics track of the Biomedical Innovation Program. This program cultivates, evaluates, and funds promising translational projects
  • Urea Cycle Disorders Consortium

    Urea cycle disorders (UCDs) are rare but devastating genetic conditions. Fifteen years ago, the Urea Cycle Disorders Consortium (UCDC) became one of the first members of the RDCRN. Since then, UCDC has flourished into an international network of 16 academic centers in the United States, Canada and Europe that provide state-of-the-art care and conduct cutting-edge clinical research. During the next

  • Phenylalanine Families and Researchers Exploring Evidence (PHEFREE)

    The Hyperphenylalaninemia Disorders Consortium studies the health, neurologic, cognitive, neuropsychiatric, patient-reported and quality-of-life outcomes in individuals with chronic elevations of the amino acid phenylalanine in blood (hyperphenylalaninemia). Elevated blood phenylalanine is typically detected at birth in the United States through newborn screening and is caused by inherited

  • Virginia Commonwealth University
    University of Nebraska Medical Center
    University Of Washington
    University Of Alabama At Birmingham
    University Of North Carolina Chapel Hill
    Johns Hopkins University
    Mayo Clinic
    Oregon Health and Science University

    Many clinical questions have arisen with the COVID-19 pandemic, from who is at greatest risk for COVID-19 infection to adverse outcomes if infected to how COVID-19 has impacted healthcare utilization patterns. To help answer these questions, and many more, the National COVID Cohort Collaborative (N3C) has integrated real-world clinical observations from across the nation into a harmonized database

  • Brittle Bone Disorders Consortium (BBD)

    Brittle bone disorders (BBDs), also known as osteogenesis imperfecta, include 13 inherited conditions involving bones that break easily. BBDs can cause deformity, chronic pain and lead to premature death. This project’s goal is to form a BBD Rare Disease Clinical Research Consortium composed of 10 medical research sites to better understand and treat BBDs. The consortium aims to explore the

  • Oregon Health and Science University

    When the COVID-19 pandemic hit in early 2020, traditional, in-person methods of community outreach and engagement (CE) had to be reimagined and redefined in order to accommodate new COVID-19 life-style and community needs. Through CE, the Oregon Clinical and Translational Research Institute (OCTRI) Community Research Hub works to connect and support researchers and community organizations (CBOs)

  • The Tillamook County Wellness (TCW) coalition, of which the Oregon CTSA (OCTRI) is a member and key supporter, scored a big win recently when Tillamook Adventist Health’s newly-created Community Well-Being Division absorbed TCW’s Wellness Coordinator position – as well as the person filling it – to head Adventist’s new Division. This move was an important step, because it confirms the importance

  • Oregon Health and Science University Logo
    Oregon Health and Science University

    OHSU is joining forces with MIT Hacking Medicine and academic and industry partners from across the Pacific Northwest to bring you the inaugural OHSU Invent-a-thon, a virtual health hackathon, October 23–25, 2020.  MIT Hacking Medicine events have directly led to the creation of numerous successful companies, gaining over $250 million in funding, and even a billion-dollar acquisition. The ideas

  • The Oregon Clinical & Translational Clinical Research Institute (OCTRI) at Oregon Health & Science University (OHSU) funded three projects for their 2020 Biomedical Innovation Program drug discovery track. The funded research covers pancreatic cancer, prostate cancer, and SARS-CoV-2. This category of funding supports drug discovery platforms and early-stage therapeutic technology projects
  • SIREN Logo

    The Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) is a clinical trials network funded by the National Institute for Neurological Disorders and Stroke (NINDS), the National Heart Lung and Blood Institute (NHLBI) and the National Center for Advancing Translational Science (NCATS). The goal of the SIREN Network is to improve the outcomes of patients with neurologic, cardiac

  • Oregon Health and Science University

    The Oregon Clinical & Translational Research Institute (OCTRI) Recruitment team pivoted its efforts early on during the COVID pandemic in order to support clinical and translational scientists in navigating the research shutdown (and now the restart of research) at Oregon Health and Science University (OHSU).

  • OCTRI announces six awardees to two tracks of the Biomedical Innovation Program: COVID-19 Rapid Response and Digital Health.

  • Two Emergency Medicine faculty researchers at Oregon Health and Science University are looking for healthcare workers to take their research survey on the impact of COVID-19 on the healthcare workforce. This is a CTSA-supported study. See below. Are you a healthcare worker that comes in contact with patients? Concerned about COVID-19’s impact on the healthcare workforce? Participate in an
  • The Oregon Clinical & Translational Research Institute (OCTRI) at Oregon Health & Science Universtiy (OHSU) pivoted rapidly to support our home institution and our state during this crisis. Our rapid response allowed us to become the central organizing and triage hub for clinical research during this time. This provided us the opportunity to demonstrate our value to OHSU and also to utilize the
  • The Center for Evidence-based Policy at Oregon Health & Science University (OHSU) recently launched CLOUD: Curated Library about Opioid Use for Decision-makers. CLOUD is a user-friendly, online repository of evidence-based, actionable materials on opioids and the opioid crisis. The opioid library has three specific audiences in mind: payers & providers, policymakers & community leaders, and

  • Oregon Health and Science University

    This video provides a brief overview of sampling constructs in qualitative research.

  • Dr. Amanda Bruegl, OHSU oncologist and OCTRI KL2 awardee, has been named a scholar of the Harold Amos Medical Faculty Development Program, which is part of The Robert Wood Johnson Foundation. Dr. Bruegl will leverage this prestigious award to expand her research on HPV and cervical cancer in Native American women.

  • Dr. David Sheridan, Assistant Professor of Emergency Medicine, and his team at Oregon Health & Science University are developing a wearable device that assesses and reports the physiological measures associated with stress dysregulation and worsening suicidality. The goal is to help adolescents identify these symptoms and therefore allow time for interventions that can help prevent emergency
  • Department Overview The CTSA Program National Center for Data to Health (CD2H) seeks an Evaluator to design and implement the evaluation and continuous improvement of CD2H. Working collaboratively with all 9 CD2H funded sites (including researchers, IT teams, data professionals, etc.), this position will perform program evaluation for the CD2H Program. The CD2H was established through a 5-year
  • The American Journal of Geriatrics published a letter to the editor by Meredith Zauflik, MPA, Recruitment Specialist at OCTRI (Portland's CTSA hub) and Elizabeth Eckstrom, MD, MPH, Director of Integrating Special Populations at OCTRI and Chief of Geriatrics at Oregon Health & Science University. In “Matching Older Research Subjects to Disease Demographics: First You Need to Know the Demographics,”